Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: Potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity

American Journal of Dermatopathology

Volumn 26, Issue 4, 2004, Pages 267-272

  Li, Ning ^a   McNiff, Jennifer ^a   Hui, Pei ^a   Manfioletti, Guidalberto ^b   Tallini, Giovanni ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

DF and DFSP; HMGA; Immunohistochemistry

Indexed keywords

BLOOD CLOTTING FACTOR 13A; CD34 ANTIGEN; HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP A2 PROTEIN; TRANSCRIPTION FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; DERMATOFIBROMA; DERMATOFIBROSARCOMA PROTUBERANS; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; GENETIC CODE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MESENCHYMOMA; PRIORITY JOURNAL; SUBCUTANEOUS FAT;

ADULT; ANTIGENS, CD34; DERMATOFIBROSARCOMA; DIAGNOSIS, DIFFERENTIAL; FACTOR XIIIA; FEMALE; HISTIOCYTOMA, BENIGN FIBROUS; HMGA PROTEINS; HMGA1A PROTEIN; HMGA2 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 3342912054     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-200408000-00001     Document Type: Article

References (28)

1. Kamino H, Jacobson M. Dermatofibroma extending into the subcutaneous tissue. Differential diagnosis from dermatofibrosarcoma protuberans. Am J Surg Pathol. 1990;14:1156-1164.
2. Abenoza P, Lillemoe T. CD34 and Factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Dermatopathol. 1993;15:429-434.
3. Cohen PR, Rapin RP, Farhood AI. Dermatofibroma and dermatofibrosarcoma protuberans: differential expression of CD34 and Factor XIIIa. Am J Dermatopathol. 1994;16:573-574.
4. Hsi ED, Nickoloff BJ. Dermatofibroma and dermatofibrosarcoma protuberans: an immunohistochemical study reveals distinctive antigenic profiles. J Dermatol Sci. 1996;11:1-9.
5. Kahn HJ, Fekete E, From L. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and Factor XIIIa. Hum Pathol. 2001;32:50-56.
6. Cribier B, Noacco G, Peltre B, et al. Stromelysin 3 expression: a useful marker for the differential diagnosis dermatofibroma versus dermatofibrosarcoma, protuberans. J Am Acad Dermatol. 2002;46:408-413.
7. Calikoglu E, Augsburger E, Chavaz P, et al. CD44 and hyaluronate in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. J Cutan Pathol. 2003;30:185-189.
8. Reeves R. Molecular biology of HMGA proteins: hubs of nuclear function. Gene. 2001;277:63-81.
9. Himing-Folz U, Wilda M, Rippe V, et al. The expression pattern of the HMGIC gene during development. Genes Chromosomes Cancer. 1998;23:350-357.
10. Gattas GJ, Quade BJ, Nowak RA, et al. HMGIC expression in human adult and fetal tissues and in uterine leiomyomata. Genes Chromosomes Cancer. 1999;25:316-322.
11. Berlingieri MT, Manfioletti G, Santoro M, et al. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol. 1995;15:1545-1553.
12. Zhou X, Benson KF, Ashar HR, et al. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature. 1995;376:771-774.
13. Tallini G, Dal Cin P. HMGI(Y) and HMGI-C dysregulation: a common occurrence in human tumors. Adv Anat Pathol. 1999;6:237-246.
14. Schoenmakers EF, Wanschura S, Mols R, et al. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet. 1995;10:436-444.
15. Kazmierczak B, Rosigkeit J, Wanschura S, et al. HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: a survey of 30 tumors. Oncogene. 1996;12:515-521.
16. Tallini G, Dal Cin P, Rhoden KJ, et al. Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations. Am J Pathol. 1997;151:37-43.
17. Kazmierczak B, Dal Cin P, Sciot R, et al. Inflammatory myofibroblastic tumor with HMGIC rearrangement. Cancer Genet Cytogenet. 1999;112:156-160.
18. Nucci MR, Weremowicz S, Neskey DM, et al. Chromosomal translocation t (8;12) induces aberrant HMGIC expression in aggressive angiomyxoma of the vulva. Genes Chromosomes Cancer. 2001;32:172-176.
19. Bemer JM, Meza-Zepeda LA, Kools PF, et al. HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas. Oncogene. 1997;14:2935-2941.
20. Battista S, Fidanza V, Fedele M, et al. The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Res. 1999;59:4793-4797.
21. Arlotta P, Tai AK, Manfioletti G, et al. Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas. J Biol Chem. 2000;275:14394-14400.
22. Hui P, Glusac EJ, Sinard JH, et al. Clonal analysis of cutaneous fibrous histiocytoma (dermatofibroma). J Cutan Pathol. 2002;29:385-389.
23. Chen TC, Kuo T, Chan HL. Dermatofibroma is a clonal proliferative disease. J Cutan Pathol. 2000;27:36-39.
24. Akagi A, Tajima S, Ishibashi A, et al. Type XVI collagen is expressed in Factor XIIIa+ monocyte-derived dermal dendrocytes and constitutes a potential substrate for Factor XIIIa. J Invest Dermatol. 2002;118:267-274.
25. Gibran NS, Nickoloff BJ, Holbrook KA. Ontogeny and characterization of factor XIIIa+ cells in developing human skin. Anat Embrvol (Berl). 1996;193:35-41.
26. Bruecks AK, Trotter MJ. Expression of desmin and smooth muscle myosin heavy chain in dermatofibromas. Arch Pathol Lab Med. 2002;126:1179-1183.
27. Ayoubi TA, Jansen E, Meulemans SM, et al.: Regulation of HMGIC expression: an architectural transcription factor involved in growth control and development. Oncogene. 1999;18:5076-5087.
28. Broberg K, Tallini G, Hoglund M, et al. The tumor-associated gene HMGIC is expressed in normal and osteoarthritis-affected synovia. Mod Pathol. 2001;14:311-317.